awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q41610309-BEB9E267-1506-41D9-B022-0BB53D909382
Q41610309-BEB9E267-1506-41D9-B022-0BB53D909382
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41610309-BEB9E267-1506-41D9-B022-0BB53D909382
Single dose methodology to assess the influence of an alpha1-adrenoceptor antagonist on uroflowmetric parameters in patients with benign prostatic hyperplasia.
P2860
Q41610309-BEB9E267-1506-41D9-B022-0BB53D909382
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41610309-BEB9E267-1506-41D9-B022-0BB53D909382
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e1beb32710c5bac3e194591480d430d674d9b82c
P2860
The Hytrin Community Assessment Trial study: a one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia. HYCAT Investigator Group.